New York, NY, November 15, 2008 – In a constantly evolving market, investors are scrambling for strategies to reduce volatility and increase alpha. Life Settlements are one of the few uncorrelated alternative asset classes providing investors means to fulfill both of these objectives.
Proverian Capital has retained Jean-Marc Joseph as Director-Investor Relations to help institutional investors navigate Life Settlements as an asset class. Jean-Marc was formerly at Bank of America as a sales and marketing officer focusing on pension funds, foundations and endowments. Prior to Bank of America, he was a team leader at J.P. Morgan Chase assisting Healthcare and Not-for-Profit entities with short and long term investment programs. While at Citigroup, Jean-Marc acted as a Sales Director focusing on Working Capital and Liquidity Management solutions globally.
Howard Zail, Chief Financial Officer commented "We are pleased to add Jean-Marc to the team to diversify our investor base and help our clients add value to their investment portfolios."
Institutional investors have a rare opportunity to partner with a premier life settlement provider and capitalize on an alternative asset in an emerging market. Life settlements represent a low market-correlated investment opportunity with a potential for superior returns. The market demographics position the industry for continued growth, affording investors significant investment opportunities. In terms of life expectancy, the most critical aspect of policy appraisal, Proverian uses a proprietary medical underwriting team and experienced substandard mortality specialists. Proverian Capital sets the industry standard for comprehensive understanding of substandard mortality and applies years of experience to its portfolio compilation process.
Contact:
Jean-Marc Joseph
Director of Investor Relations
Proverian Capital, LLC
T (212)562-2646 x143
E jjoseph@proverian.com